BindingDB logo
myBDB logout

18 articles for Bayer Research Center


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDArticle TitlePublishedDeposition
16806919 4,5-Disubstituted cis-pyrrolidinones as inhibitors of type II 17beta-hydroxysteroid dehydrogenase. Part 3. Identification of lead candidate. 14-AUG-2006 08-DEC-2012
11591521 Discovery of heterocyclic ureas as a new class of raf kinase inhibitors: identification of a second generation lead by a combinatorial chemistry approach. 09-OCT-2001 04-OCT-2012
15149665 In vitro SAR of (5-(2H)-isoxazolonyl) ureas, potent inhibitors of hormone-sensitive lipase. 19-MAY-2004 10-NOV-2009
11677133 Discovery and parallel synthesis of a new class of cathepsin K inhibitors. 25-OCT-2001 10-NOV-2009
10999468 1-Phenyl-5-pyrazolyl ureas: potent and selective p38 kinase inhibitors. 26-DEC-2000 10-NOV-2009
12419375 Integration of optimized substituent patterns to produce highly potent 4-aryl-pyridine glucagon receptor antagonists. 06-NOV-2002 10-NOV-2009
16275080 Substituted indanylacetic acids as PPAR-alpha-gamma activators. 25-NOV-2005 10-NOV-2009
17574417 SAR of a novel 'Anthranilamide Like' series of VEGFR-2, multi protein kinase inhibitors for the treatment of cancer. 10-JUL-2007 10-NOV-2009
17601734 Indanylacetic acids as PPAR-delta activator insulin sensitizers. 10-JUL-2007 10-NOV-2009
15890515 4,5-Disubstituted cis-pyrrolidinones as inhibitors of type II 17beta-hydroxysteroid dehydrogenase. Part 2. SAR. 31-MAY-2005 10-NOV-2009
11965376 Optimization of the 4-aryl group of 4-aryl-pyridine glucagon antagonists: development of an efficient, alternative synthesis. 19-APR-2002 10-NOV-2009
10999467 Discovery of a new class of p38 kinase inhibitors. 26-DEC-2000 10-NOV-2009
11814820 Discovery of 5-hydroxyalkyl-4-phenylpyridines as a new class of glucagon receptor antagonists. 07-MAR-2002 10-NOV-2009
14741289 Omega-carboxypyridyl substituted ureas as Raf kinase inhibitors: SAR of the amide substituent. 26-JAN-2004 10-NOV-2009
12270167 Solid-phase synthesis and investigation of benzofurans as selective estrogen receptor modulators. 24-SEP-2002 10-NOV-2009
12039561 Synthesis and pharmacological characterization of a potent, orally active p38 kinase inhibitor. 31-MAY-2002 10-NOV-2009
11140741 p38 kinase inhibitors for the treatment of arthritis and osteoporosis: thienyl, furyl, and pyrrolyl ureas. 03-JAN-2001 10-NOV-2009
15808450 Substituted aminobenzimidazole pyrimidines as cyclin-dependent kinase inhibitors. 05-APR-2005 10-NOV-2009